Tardbp Mutations In Amyotrophic Lateral Sclerosis plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Mutations in the TARDBP gene, which encodes the TDP-43 protein, are a well-established cause of familial amyotrophic lateral sclerosis (ALS)[1][2]. TDP-43 is the major pathological protein in virtually all ALS cases (except those caused by SOD1 or FUS mutations), making understanding TARDBP mutations crucial for comprehending ALS pathogenesis.
The TARDBP gene is located on chromosome 1p36.22 and encodes:
Over 50 pathogenic TARDBP mutations have been identified:
| Mutation | Location | Frequency | Phenotype |
|---|---|---|---|
| A382T | C-terminal | Most common | Classic ALS |
| M337V | C-terminal | Common | ALS/FTD |
| G298S | C-terminal | Rare | Early onset |
| Q331K | C-terminal | Rare | Variable |
| N345K | C-terminal | Rare | ALS |
| D169G | RRM | Rare | FTD |
TDP-43 is a nuclear RNA-binding protein that:
TDP-43 inclusions are the hallmark of ALS:
| Mutation | Onset | Progression | Notes |
|---|---|---|---|
| A382T | ~50 years | Variable | Most common, Italy cluster |
| M337V | ~52 years | Variable | ALS/FTD possible |
| G298S | ~45 years | Variable | Early onset |
| Biomarker | Relevance |
|---|---|
| Total TDP-43 in CSF | May be elevated |
| Neurofilament light chain (NfL) | Disease progression marker |
| Phosphorylated TDP-43 | Diagnostic in research |
TDP-43 pathology is present in:
SOD1-ALS: Rare, usually absent
FUS-ALS: TDP-43 negative inclusions
C9orf72: TDP-43 positive
Sporadic ALS: Universal TDP-43 pathology
Tardbp Mutations In Amyotrophic Lateral Sclerosis plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Tardbp Mutations In Amyotrophic Lateral Sclerosis has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
This section highlights recent publications relevant to this disease.